Trial
NCT03991299
Investigating Effects of BOTOX on Weight Loss and Glucose Tolerance in Obese, Type 2 Diabetic Subjects
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Vanderbilt University Medical Center
Collaborators
—
Condition
Obese
Intervention
Botox 200 UNT Injection
Why stopped
Sponsor Decision.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-02-28